Lunate-Capital

AI_NATIVE detailed information: This accession holds the following tickers:[
  "RVMD",
  "LINE",
  "NMRA",
  null
]

13F-HR • 2025-03-31

Data Enrichment

75% identified

3 identified1 unidentified

Holdings

Manager:

4 positions • $171.2M total value

Manager:

Search and click to pin securities to the top

Sort by:

Revolution Medicines, Inc.

Shares:2.2M

Value:$77.7M

% of Portfolio:45.4% ($77.7M/$171.2M)

78781J109

Shares:3.0M

Value:$56.3M

% of Portfolio:32.9% ($56.3M/$171.2M)

Lineage, Inc.

Shares:600.0K

Value:$35.2M

% of Portfolio:20.5% ($35.2M/$171.2M)

Neumora Therapeutics, Inc.

Shares:2.1M

Value:$2.1M

% of Portfolio:1.2% ($2.1M/$171.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Revolution Medicines, Inc.(RVMDcusip76155X100)	2.2M	QoQ- YoY-	All Managers (Combined)	$77.7M	45.4% ($77.7M/$171.2M)	QoQ- YoY-
(cusip78781J109)✕	3.0M	QoQ- YoY-	All Managers (Combined)	$56.3M	32.9% ($56.3M/$171.2M)	QoQ- YoY-
Lineage, Inc.(LINEcusip53566V106)	600.0K	QoQ- YoY-	All Managers (Combined)	$35.2M	20.5% ($35.2M/$171.2M)	QoQ- YoY-
Neumora Therapeutics, Inc.(NMRAcusip640979100)	2.1M	QoQ- YoY-	All Managers (Combined)	$2.1M	1.2% ($2.1M/$171.2M)	QoQ- YoY-